Results 251 to 260 of about 24,516 (282)

Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome

American Society of Nephrology. Clinical Journal, 2023
Visual Abstract Background Eculizumab is a monoclonal antibody for the treatment of atypical hemolytic uremic syndrome (aHUS). Kidney damage, a common condition in patients with aHUS, may result in proteinuria.
Mendy ter Avest, Hilbert Steenbreker, R. Bouwmeester, Caroline Duineveld, K. Wijnsma, L. P. van den Heuvel, S. Langemeijer, J. Wetzels, N. C. van de Kar, R. ter Heine   +9 more
semanticscholar   +1 more source

Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study

Therapeutic Advances in Neurological Disorders
Background: Thymoma-associated myasthenia gravis (TAMG) is a subtype of myasthenia gravis (MG) that is associated with more severe symptoms and a relatively poor prognosis.
Lei Jin, D. He, Quantao Zeng, Song Tan, Jianquan Shi, Ying Liu, Zhangyu Zou, Jie Song, Chong Yan, Xiao Huan, Yuan Wang, Lei Yang, Jianying Xi, Zongtai Wu, Ziqi Liu, Jianming Zheng, Chongbo Zhao, Xianglin Chu, S. Luo   +18 more
semanticscholar   +1 more source

Eculizumab

Reactions Weekly
  +11 more sources

Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports

Expert Opinion on Drug Safety
Background Most of the safety data regarding eculizumab came from clinical trials, while its safety information in the real world is still limited.
Zhihui Zhang, Xin Liu, Jinlan Zhang, Bo Zhang   +3 more
semanticscholar   +1 more source

Eculizumab

Reactions Weekly, 2022
  +4 more sources

Eculizumab

Reactions Weekly, 2018
  +7 more sources

Starting eculizumab as rescue therapy in refractory myasthenic crisis

Neurological Sciences, 2023
C. Vinciguerra, L. Bevilacqua, A. Toriello, A. Iovino, G. Piscosquito, G. Calicchio, P. Barone   +6 more
semanticscholar   +1 more source

Eculizumab

Reactions Weekly, 2020
  +5 more sources

Eculizumab

Reactions Weekly, 2019
  +5 more sources

Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.

European Review for Medical and Pharmacological Sciences, 2020
F. Diurno, F. Numis, G. Porta, F. Cirillo, S. Maddaluno, A. Ragozzino, P. Negri, C. Gennaro, A. Pagano, E. Allegorico, L. Bressy, G. Bosso, A. Ferrara, C. Serra, A. Montisci, M. D’Amico, S. Morello, G. D. Costanzo, A. Tucci, P. Marchetti, U. D. Vincenzo, I. Sorrentino, A. Casciotta, M. Fusco, C. Buonerba, M. Berretta, Manuela Ceccarelli, G. Nunnari, Y. Diessa, S. Cicala, G. Facchini   +30 more
semanticscholar   +1 more source